PT2670765T - Triterpenoides modificados em c-17 e c-3 com atividade inibidora da maturação do vih - Google Patents

Triterpenoides modificados em c-17 e c-3 com atividade inibidora da maturação do vih

Info

Publication number
PT2670765T
PT2670765T PT127029478T PT12702947T PT2670765T PT 2670765 T PT2670765 T PT 2670765T PT 127029478 T PT127029478 T PT 127029478T PT 12702947 T PT12702947 T PT 12702947T PT 2670765 T PT2670765 T PT 2670765T
Authority
PT
Portugal
Prior art keywords
inhibitory activity
hiv maturation
maturation inhibitory
modified triterpenoids
triterpenoids
Prior art date
Application number
PT127029478T
Other languages
English (en)
Inventor
Regueiro Ren Alicia
Liu Zheng
Swidorski Jacob
A Meanwell Nicholas
Chen Yan
Sin Ny
Lee Venables Brian
Yuen Sit Sing
Chen Jie
Original Assignee
Viiv Healthcare Uk No 4 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare Uk No 4 Ltd filed Critical Viiv Healthcare Uk No 4 Ltd
Publication of PT2670765T publication Critical patent/PT2670765T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
PT127029478T 2011-01-31 2012-01-27 Triterpenoides modificados em c-17 e c-3 com atividade inibidora da maturação do vih PT2670765T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161437893P 2011-01-31 2011-01-31

Publications (1)

Publication Number Publication Date
PT2670765T true PT2670765T (pt) 2018-01-08

Family

ID=45567147

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127029478T PT2670765T (pt) 2011-01-31 2012-01-27 Triterpenoides modificados em c-17 e c-3 com atividade inibidora da maturação do vih

Country Status (24)

Country Link
US (3) US8846647B2 (pt)
EP (1) EP2670765B1 (pt)
JP (1) JP6001560B2 (pt)
KR (1) KR101886467B1 (pt)
CN (1) CN103429607B (pt)
AR (1) AR085053A1 (pt)
AU (1) AU2012212509B2 (pt)
BR (1) BR112013019419A2 (pt)
CA (1) CA2826113C (pt)
CL (1) CL2013002185A1 (pt)
CO (1) CO6751275A2 (pt)
EA (1) EA022470B1 (pt)
ES (1) ES2653847T3 (pt)
IL (1) IL227678B (pt)
MA (1) MA34909B1 (pt)
MY (1) MY162186A (pt)
PE (1) PE20141152A1 (pt)
PT (1) PT2670765T (pt)
SG (1) SG192144A1 (pt)
TN (1) TN2013000321A1 (pt)
TW (1) TWI628188B (pt)
UY (1) UY33886A (pt)
WO (1) WO2012106190A1 (pt)
ZA (1) ZA201306546B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911208B1 (pt) 2008-04-18 2021-05-25 Reata Pharmaceuticals, Inc Compostos moduladores inflamatórios antioxidantes, seu uso, e composição farmacêutica
HUE041221T2 (hu) 2008-04-18 2019-05-28 Reata Pharmaceuticals Inc Antioxidáns gyulladás modulátorok: a C-17 atomon amino- és más módosításokkal rendelkezõ oleanolsav-származékok
JP5588966B2 (ja) 2008-04-18 2014-09-10 リアタ ファーマシューティカルズ インコーポレイテッド 抗酸化炎症モジュレーター：ｃ−１７同族体化オレアノール酸誘導体
BRPI0911105B1 (pt) 2008-04-18 2022-11-08 Reata Pharmaceuticals, Inc Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
KR102000301B1 (ko) 2010-12-17 2019-07-15 리아타 파마슈티컬즈, 아이엔씨. 산화방지성 염증 조절제로서의 피라졸릴 및 피리미디닐 트리사이클릭 엔온
JP6000283B2 (ja) * 2011-01-31 2016-09-28 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｈｉｖ成熟阻害剤としてのｃ−３修飾ベツリン酸誘導体のｃ−２８アミン
SG193404A1 (en) 2011-03-11 2013-10-30 Reata Pharmaceuticals Inc C4-monomethyl triterpenoid derivatives and methods of use thereof
ES2611727T3 (es) 2011-09-21 2017-05-10 VIIV Healthcare UK (No.5) Limited Derivados de ácido betulínico novedosos con actividad antivírica
US8906889B2 (en) * 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
PE20150160A1 (es) 2012-04-27 2015-02-19 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de bardoxolona metilo, formas polimorficas y metodos de uso de los mismos
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
CA2881935A1 (en) * 2012-08-15 2014-02-20 Glaxo Group Limited Process for preparing a 1-(2-haolethyl)-4-piperidine carboxylate intermediate useful in the synthesis of umeclidinium bromide
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US9278912B2 (en) 2012-09-10 2016-03-08 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
PL2892912T3 (pl) 2012-09-10 2019-10-31 Reata Pharmaceuticals Inc C17-alkanodiylowe i alkenodiylowe pochodne kwasu oleanolowego i sposoby ich zastosowania
EA027371B1 (ru) * 2013-02-06 2017-07-31 Бристол-Майерс Сквибб Компани C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
CN105102468A (zh) * 2013-02-25 2015-11-25 百时美施贵宝公司 用于治疗hiv的c-3烷基和烯基修饰的桦木酸衍生物
NZ724644A (en) 2014-04-11 2023-07-28 Viiv Healthcare Uk No 4 Ltd Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
WO2015195776A1 (en) 2014-06-19 2015-12-23 Bristol-Myers Squibb Company Betulinic acid derivatives with hiv maturation inhibitory activity
CN107250153A (zh) 2014-11-14 2017-10-13 Viiv保健英国第五有限公司 氧代羽扇豆烯衍生物
US10047118B2 (en) 2014-11-14 2018-08-14 VIIV Healthcare UK (No.5) Limited C17-aryl substituted betulinic acid analogs
CA2981056A1 (en) 2015-04-14 2016-10-20 ViiV Healthcare UK (No.4) Limited Methods of producing an hiv maturation inhibitor
EP3328876A1 (en) 2015-07-28 2018-06-06 Glaxosmithkline Intellectual Property (No. 2) Limited Betuin derivatives for preventing or treating hiv infections
BR112018001537A2 (pt) 2015-07-28 2018-09-18 Glaxosmithkline Ip No 2 Ltd composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratamento e para prevenção de uma infecção por hiv em um indivíduo, e, uso de um composto ou sal
WO2017025901A1 (en) * 2015-08-11 2017-02-16 Hetero Research Foundation Novel c28-analogues with c3-modifications of triterpene derivatives as hiv inhibitors
ES2865163T3 (es) 2015-09-23 2021-10-15 Reata Pharmaceuticals Inc Derivados de ácido oleanólico modificado en C4 para la inhibición de il-17 y otros usos
US20180273579A1 (en) 2015-09-24 2018-09-27 Glaxosmithkline Intellectual Property (No.2) Limited Compounds with hiv maturation inhibitory activity
BR112018010163A2 (pt) 2015-11-20 2018-11-21 Viiv Healthcare Uk No 4 Ltd formulação, e, método para tratamento de infecção por hiv
WO2017125870A1 (en) 2016-01-20 2017-07-27 Glaxosmithkline Intellectual Property (No.2) Limited Amine derivatives of lupanes with hiv maturation inhibitory activity
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
WO2018002849A1 (en) * 2016-06-30 2018-01-04 VIIV Healthcare UK (No.5) Limited Triterpenoid inhibitors of human immunodeficiency virus replication
WO2018044822A1 (en) * 2016-08-31 2018-03-08 Viiv Healthcare Company Combinations and uses and treatments thereof
MX2020001412A (es) 2017-08-04 2020-08-03 Ardelyx Inc Compuestos y métodos para tratar la hiperpotasemia.
JP6926939B2 (ja) * 2017-10-23 2021-08-25 東京エレクトロン株式会社 半導体装置の製造方法
JP6977474B2 (ja) * 2017-10-23 2021-12-08 東京エレクトロン株式会社 半導体装置の製造方法
PT3784349T (pt) 2018-04-24 2024-01-22 Viiv Healthcare Uk No 5 Ltd Compostos com atividade inibidora de maturação do hiv
PL237998B1 (pl) 2018-05-28 2021-06-28 Narodowy Inst Lekow Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie
TW202045523A (zh) 2019-02-07 2020-12-16 美商阿德利克斯公司 用於治療高鉀血症之化合物及方法
CN113727989B (zh) 2019-02-11 2024-02-13 熙德隆制药有限公司 作为hiv抑制剂的新型三萜衍生物
GB2598300A (en) * 2020-08-21 2022-03-02 Univ Durham Cross-linking method and applications in bioconjugation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
US20020137755A1 (en) 2000-12-04 2002-09-26 Bilodeau Mark T. Tyrosine kinase inhibitors
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
WO2004089357A2 (en) 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
CA2560266A1 (en) 2004-03-17 2005-09-29 Panacos Pharmaceuticals, Inc. Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
US8067620B2 (en) 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
WO2008127364A2 (en) * 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20090105203A1 (en) 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
WO2009100532A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. NOVEL 17ß LUPANE DERIVATIVES
US9067966B2 (en) * 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
CN103038245B (zh) * 2010-06-04 2015-03-25 百时美施贵宝公司 作为hiv成熟抑制剂的c-3经修饰的桦木酸衍生物
RS54239B1 (en) * 2010-06-04 2015-12-31 Bristol-Myers Squibb Company C-28 MODIFIED C-3 BETULINIC ACID DERIVATIVES AS INHIBITORS OF HIV AGING

Also Published As

Publication number Publication date
EA201391127A1 (ru) 2013-12-30
TWI628188B (zh) 2018-07-01
US8846647B2 (en) 2014-09-30
AU2012212509A1 (en) 2013-09-19
MA34909B1 (fr) 2014-02-01
MY162186A (en) 2017-05-31
CA2826113C (en) 2018-09-04
JP2014503595A (ja) 2014-02-13
US20130035318A1 (en) 2013-02-07
WO2012106190A1 (en) 2012-08-09
CL2013002185A1 (es) 2013-12-27
UY33886A (es) 2012-07-31
EA022470B1 (ru) 2016-01-29
JP6001560B2 (ja) 2016-10-05
TW201309717A (zh) 2013-03-01
TN2013000321A1 (en) 2015-01-20
IL227678A0 (en) 2013-09-30
PE20141152A1 (es) 2014-09-22
EP2670765A1 (en) 2013-12-11
KR101886467B1 (ko) 2018-08-07
AR085053A1 (es) 2013-08-07
CN103429607A (zh) 2013-12-04
ZA201306546B (en) 2015-03-25
CN103429607B (zh) 2016-02-17
US20160151387A1 (en) 2016-06-02
AU2012212509B2 (en) 2016-01-21
CO6751275A2 (es) 2013-09-16
NZ614871A (en) 2014-06-27
IL227678B (en) 2018-04-30
KR20140016279A (ko) 2014-02-07
CA2826113A1 (en) 2012-08-09
EP2670765B1 (en) 2017-10-18
ES2653847T3 (es) 2018-02-09
US20140343000A1 (en) 2014-11-20
SG192144A1 (en) 2013-08-30
BR112013019419A2 (pt) 2019-12-03

Similar Documents

Publication Publication Date Title
ZA201306546B (en) C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
HK1204608A1 (en) C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity hiv c-3
EP2763569A4 (en) CHAIR AND SUPPORT THEREFOR
LT2683731T (lt) C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai
PL2686331T3 (pl) Rebaudiozyd b i pochodne
EP2717931A4 (en) ASSOCIATIONS AND RELATED METHODS
EP2761294A4 (en) PANELS AND METHODS OF BIODOSIMETRY
IL235465A (en) Biocyclic amines in position c-17 of tritrapenoids as maturation inhibitors of HIV virus
HK1202553A1 (en) Lupane triterpenoid derivatives and pharmaceutical use thereof
HK1205218A1 (en) Construction panel and manufacture thereof
IL229633A0 (en) A combination that includes Omclidinium and a corticosteroid
EP2756832A4 (en) FASTENING ELEMENT AND FASTENING PART
EP2682145A4 (en) SYRINGE AND SYRINGE ASSEMBLY
EP2708532A4 (en) 4-AMINOQUINAZOLINE DERIVATIVES AND USES THEREOF
IL216345A0 (en) Wing and devices therefor
HK1200358A1 (en) Plant steroids and uses thereof
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
EP2716359A4 (en) COMPLEX AND USES THEREOF
EP2712348A4 (en) DISTRIBUTOR AND METHODS
PL2688418T3 (pl) Bogata w stygmasterol kompozycja fitosterolowa i jej zastosowania
EP2744420A4 (en) METHODS AND DEVICES FOR HANDLING AND FIXING TISSUE
GB201107656D0 (en) Short back and sides
AU2011900412A0 (en) Combination Kneeler and Seat
GB201119443D0 (en) GoWinging Concept and patent
GB201118317D0 (en) Intrathermic and interthermic extractive thermiats